Sigma Planning Corp’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-30,700
Closed -$399K 943
2018
Q1
$399K Buy
30,700
+3,400
+12% +$44.2K 0.03% 503
2017
Q4
$251K Buy
27,300
+12,300
+82% +$113K 0.02% 677
2017
Q3
$121K Buy
15,000
+1,000
+7% +$8.07K 0.01% 805
2017
Q2
$81K Sell
14,000
-85
-0.6% -$492 0.01% 764
2017
Q1
$61K Buy
+14,085
New +$61K 0.01% 758